Healthcare resource utilization in patients with newly diagnosed atrial fibrillation in the United States

被引:6
|
作者
Zeitler, Emily P. [1 ,2 ]
Ronk, Christopher J. [3 ]
Cockerham, Alex [3 ]
Huse, Samuel [4 ]
McKindley, David S. [3 ]
Kim, Michael H. [5 ]
机构
[1] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03756 USA
[2] Dartmouth Inst, Lebanon, NH 03756 USA
[3] Sanofi, Bridgewater, NJ USA
[4] Evidera, Waltham, MA USA
[5] Creighton Univ, Sch Med & CHI Hlth, Omaha, NE 68178 USA
关键词
Atrial fibrillation; antiarrhythmic drugs; dronedarone; first-line antiarrhythmics; healthcare resource utilization; DRONEDARONE; MORTALITY; IMPACT; COSTS; POPULATION; MANAGEMENT; EVENTS; RISK;
D O I
10.1080/14737167.2022.2045955
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objectives To summarize healthcare resource utilization (HCRU) in patients with newly diagnosed (incident) paroxysmal or persistent atrial fibrillation (AF). Methods This retrospective, observational cohort study assessed HCRU among patients with incident paroxysmal or persistent AF using data from 1 January 2015 to 30 September 2019 in the IBM MarketScan (R) Research Databases. Results A total of 50,796 patients were identified in the overall incident AF cohort. Rates of all-cause inpatient hospital stays, all-cause emergency room visits, and all-cause outpatient visits in the overall incident cohort were 46.8, 114.7, and 2,752.7 events per 100 patient-years (PY), respectively. Rates of cardiovascular-related inpatient stays for the overall population were 11.3 events per 100 PY. During follow-up, 50.4% of the overall cohort filled prescriptions for direct-acting oral anticoagulants and 5.0% had catheter ablation. Conclusions Advances in anticoagulation and ablation have been realized since previously published HCRU analyses of patients with atrial fibrillation. This update suggests that HCRU among patients with incident AF in the US remains high with some subgroups of patients receiving more specialized care.
引用
收藏
页码:763 / 771
页数:9
相关论文
共 50 条
  • [1] Healthcare resource utilization and costs for patients with postoperative atrial fibrillation in the United States
    Park, Tae Jin
    Hansen, Ryan
    Gillard, Patrick
    Shah, Darshini
    Ferguson, William G.
    Piccini, Jonathan
    Romano, Matthew A.
    Devine, Beth
    JOURNAL OF MEDICAL ECONOMICS, 2023, 26 (01) : 1417 - 1423
  • [2] Healthcare Resource Utilization in Patients with Newly Diagnosed Atrial Fibrillation: A Global Analysis from the GARFIELD-AF Registry
    Mantovani, Lorenzo G. G.
    Cozzolino, Paolo
    Ferrara, Pietro
    Virdone, Saverio
    Camm, A. John
    Verheugt, Freek W. A.
    Bassand, Jean-Pierre
    Turpie, Alexander G. G.
    Hacke, Werner
    Kayani, Gloria
    Goldhaber, Samuel Z. Z.
    Goto, Shinya
    Pieper, Karen S. S.
    Gersh, Bernard J. J.
    Fox, Keith A. A.
    Haas, Sylvia
    van Eickels, Martin
    Kakkar, Ajay K. K.
    HEALTHCARE, 2023, 11 (05)
  • [3] Health Care Resource Utilization, Costs, and Persistence in Patients Newly Diagnosed as Having Nonvalvular Atrial Fibrillation and Newly Treated With Dabigatran versus Warfarin in the United States
    Bancroft, Tim
    Lim, Jonathan
    Wang, Cheng
    Sander, Stephen D.
    Swindle, Jason P.
    CLINICAL THERAPEUTICS, 2016, 38 (03) : 545 - 556
  • [4] Healthcare resource utilization among patients diagnosed with idiopathic pulmonary fibrosis in the United States
    Wu, Ning
    Yu, Yanni F.
    Chuang, Chien-Chia
    Wang, Rosa
    Benjamin, Nicole N.
    Coultas, David B.
    JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (04) : 249 - 257
  • [5] TREND IN THE UTILIZATION OF PHARMACOLOGICAL AND NON-PHARMACOLOGICAL TREATMENT STRATEGIES IN THE MANAGEMENT OF NEWLY DIAGNOSED ATRIAL FIBRILLATION PATIENTS IN THE UNITED STATES
    Kashyap, A.
    Li, C.
    VALUE IN HEALTH, 2011, 14 (03) : A50 - A50
  • [6] Healthcare Resource Use and Expenditures in Patients Newly Diagnosed with Paroxysmal Supraventricular Tachycardia in the United States
    Sacks, Naomi C.
    Everson, Katie
    Cyr, Philip L.
    Preib, Madison T.
    Wood, David R.
    Pokorney, Sean D.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 8 - 9
  • [7] Health Care Resource Utilization and Costs Among Newly Diagnosed and Oral Anticoagulant-Naive Nonvalvular Atrial Fibrillation Patients Treated with Dabigatran or Warfarin in the United States
    Jain, Rahul
    Fu, An-Chen
    Lim, Jonathan
    Wang, Cheng
    Elder, Jessica
    Sander, Stephen D.
    Tan, Hiangkiat
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (01): : 73 - +
  • [8] Healthcare resource utilization and expenditures among newly-diagnosed elderly non-valvular atrial fibrillation patients initiating oral anticoagulants
    Chowdhury, Ritam
    Franchino-Elder, Jessica
    Wang, Li
    Yuce, Huseyin
    Wang, Cheng
    Hartaigh, Briain O.
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (12) : 1338 - 1350
  • [9] TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILIZATION AND ASSOCIATED COSTS BY LINE OF THERAPY IN NEWLY DIAGNOSED MERKEL CELL CANCER PATIENTS IN THE UNITED STATES
    Kearney, M.
    Boutmy, E.
    Locker, M.
    Penalvo, J.
    Bharmal, M.
    VALUE IN HEALTH, 2018, 21 : S46 - S46
  • [10] Prevalence of Diagnosed Atrial Fibrillation in the United States
    Noubiap, Jean Jacques
    Tang, Janet J.
    Teraoka, Justin T.
    Dewland, Thomas A.
    Marcus, Gregory M.
    CIRCULATION, 2023, 148